Karan Bedi

1.3k total citations
25 papers, 729 citations indexed

About

Karan Bedi is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Karan Bedi has authored 25 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in Karan Bedi's work include RNA Research and Splicing (11 papers), RNA modifications and cancer (8 papers) and RNA and protein synthesis mechanisms (6 papers). Karan Bedi is often cited by papers focused on RNA Research and Splicing (11 papers), RNA modifications and cancer (8 papers) and RNA and protein synthesis mechanisms (6 papers). Karan Bedi collaborates with scholars based in United States, United Kingdom and Brazil. Karan Bedi's co-authors include Mats Ljungman, Michelle T. Paulsen, Thomas E. Wilson, Brian Magnuson, Artur Veloso, Jayendra Prasad, Killeen S. Kirkconnell, Sami J. Barmada, Xia Jiang and Marcin Cieślik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Karan Bedi

24 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karan Bedi United States	15	565	117	98	81	71	25	729
David Clynes United Kingdom	14	973 1.7×	89 0.8×	93 0.9×	59 0.7×	138 1.9×	18	1.1k
Sven Fraterman Germany	11	973 1.7×	131 1.1×	84 0.9×	39 0.5×	57 0.8×	11	1.2k
Guozhi Zhu United States	7	384 0.7×	65 0.6×	69 0.7×	71 0.9×	29 0.4×	7	560
John Luff Australia	9	473 0.8×	76 0.6×	125 1.3×	33 0.4×	33 0.5×	11	563
Amy Heidersbach United States	12	864 1.5×	89 0.8×	283 2.9×	40 0.5×	56 0.8×	17	1.0k
Ashley R. Woodfin United States	13	1.1k 1.9×	72 0.6×	99 1.0×	43 0.5×	146 2.1×	18	1.2k
Ken Fujimura United States	13	593 1.0×	65 0.6×	62 0.6×	40 0.5×	28 0.4×	20	697
Marta M. Fay United States	14	1.3k 2.2×	34 0.3×	144 1.5×	67 0.8×	56 0.8×	15	1.3k
Arnab Nayak Germany	14	529 0.9×	149 1.3×	64 0.7×	45 0.6×	19 0.3×	24	724
Agnese Cristini France	10	711 1.3×	158 1.4×	54 0.6×	27 0.3×	17 0.2×	14	780

Countries citing papers authored by Karan Bedi

Since Specialization

Citations

This map shows the geographic impact of Karan Bedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karan Bedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karan Bedi more than expected).

Fields of papers citing papers by Karan Bedi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karan Bedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karan Bedi. The network helps show where Karan Bedi may publish in the future.

Co-authorship network of co-authors of Karan Bedi

This figure shows the co-authorship network connecting the top 25 collaborators of Karan Bedi. A scholar is included among the top collaborators of Karan Bedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karan Bedi. Karan Bedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shao, Qing, et al.. (2025). STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphoma. Leukemia. 39(4). 899–908.

Sekhar, Sreeja C., Karan Bedi, Marcin Iwanicki, et al.. (2025). Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer. Molecular Cancer Therapeutics. 24(4). 639–656. 1 indexed citations

Feng, Ying, Karan Bedi, Maranne Green, et al.. (2025). SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction. Journal of Clinical Investigation. 135(11). 1 indexed citations

Shao, Qing, Karan Bedi, Surinder Kumar, et al.. (2024). Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia. Leukemia. 39(1). 112–121. 1 indexed citations

Yang, Jing, Hong Sun Kim, Feng Tian, et al.. (2022). KDM6A Loss Recruits Tumor-Associated Neutrophils and Promotes Neutrophil Extracellular Trap Formation in Pancreatic Cancer. Cancer Research. 82(22). 4247–4260. 35 indexed citations

Chua, Jason P., Karan Bedi, Michelle T. Paulsen, et al.. (2022). Myotubularin-related phosphatase 5 is a critical determinant of autophagy in neurons. Current Biology. 32(12). 2581–2595.e6. 12 indexed citations

Magnuson, Brian, Karan Bedi, Bartlomiej Bartkowiak, et al.. (2022). CDK12 regulates co-transcriptional splicing and RNA turnover in human cells. iScience. 25(9). 105030–105030. 13 indexed citations

Bedi, Karan, et al.. (2021). Cotranscriptional splicing efficiencies differ within genes and between cell types. RNA. 27(7). 829–840. 17 indexed citations

Jeyarajan, Sivakumar, Jing Yang, Yumei Gu, et al.. (2021). KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Noncanonical Activin Pathway. Cellular and Molecular Gastroenterology and Hepatology. 13(2). 643–667. 28 indexed citations

10.

Surowiec, Rachel K., Carlos E. Espinoza, Ranjit K. Mehta, et al.. (2020). Transcriptomic Analysis of Diffuse Intrinsic Pontine Glioma (DIPG) Identifies a Targetable ALDH-Positive Subset of Highly Tumorigenic Cancer Stem-like Cells. Molecular Cancer Research. 19(2). 223–239. 22 indexed citations

11.

Jalihal, Ameya P., Sethuramasundaram Pitchiaya, Lanbo Xiao, et al.. (2020). Multivalent Proteins Rapidly and Reversibly Phase-Separate upon Osmotic Cell Volume Change. Molecular Cell. 79(6). 978–990.e5. 87 indexed citations

12.

Figueroa‐Romero, Claudia, Lucy M. Hinder, Karan Bedi, et al.. (2018). Abnormal RNA stability in amyotrophic lateral sclerosis. Nature Communications. 9(1). 2845–2845. 109 indexed citations

13.

Galbán, Stefanie, Carlos E. Espinoza, Kevin Heist, et al.. (2017). A Bifunctional MAPK/PI3K Antagonist for Inhibition of Tumor Growth and Metastasis. Molecular Cancer Therapeutics. 16(11). 2340–2350. 15 indexed citations

14.

Ljungman, Mats, et al.. (2017). The role of H3K79 methylation in transcription and the DNA damage response. Mutation Research/Reviews in Mutation Research. 780. 48–54. 18 indexed citations

15.

Paulsen, Michelle T., Karan Bedi, Nathaniel K. Berg, et al.. (2017). Transcriptional and post-transcriptional regulation of the ionizing radiation response by ATM and p53. Scientific Reports. 7(1). 43598–43598. 31 indexed citations

16.

Magnuson, Brian, Karan Bedi, & Mats Ljungman. (2016). Genome stability versus transcript diversity. DNA repair. 44. 81–86. 8 indexed citations

17.

Magnuson, Brian, Artur Veloso, Killeen S. Kirkconnell, et al.. (2015). Identifying transcription start sites and active enhancer elements using BruUV-seq. Scientific Reports. 5(1). 17978–17978. 23 indexed citations

18.

Veloso, Artur, Michelle T. Paulsen, Nathan Berg, et al.. (2013). Correction: Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin. PLoS ONE. 8(12). 15 indexed citations

19.

Veloso, Artur, Michelle T. Paulsen, Nathaniel K. Berg, et al.. (2013). Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin. PLoS ONE. 8(10). e78190–e78190. 31 indexed citations

20.

Paulsen, Michelle T., Artur Veloso, Jayendra Prasad, et al.. (2013). Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA. Methods. 67(1). 45–54. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact